Diantha Duvall, M.B.A., CPA

Diantha Duvall is an experienced financial and business leader in the life sciences sector who currently serves as Chief Financial Officer of Genocea, a leading cancer immunotherapy company. Prior to joining Genocea in 2019, Ms. Duvall held several positions of increasing responsibility including Vice President, Controller, Chief Accounting Officer at Bioverativ, Inc., U.S., Global Commercial Controller at Biogen and Executive Director at Merck and Co. While at Merck, her experiences spanned roles in venture investment, business development, joint ventures and alliances, as well as operational controls and technical accounting. In addition, she gained extensive experience in SEC reporting, Sarbanes Oxley compliance, transaction support and risk management while at PricewaterhouseCoopers. Ms. Duvall received a B.S. in economics and public policy from Colby College and an M.S. in accounting and an M.B.A. from Northeastern University. Ms. Duvall is a Certified Public Accountant (CPA) licensed in the state of Massachusetts.